TY - JOUR
TI - Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2022/10/12
VL - 45
IS - 6
DO - 10.18773/austprescr.2022.071
LA - eng
UR - https://australianprescriber.tg.org.au/articles/decitabine-cedazuridine-for-chronic-myelomonocytic-leukaemia-myelodysplastic-syndromes.html
KW - cedazuridine
KW - chronic myelomonocytic leukaemia
KW - decitabine
KW - Inqovi
KW - myelodysplastic syndromes
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -